Company / Operating Cash Flow per Share
MADRIGAL PHARMACEUTICALS, INC. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$8.61
FY2025
5-year range
-$22.92 / -$8.61
FY2021-FY2025
Trend
+62.4%
vs FY2024
Sector context
#205 of 212
Health Care
What the data says
Among 212 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the bottom 3% for operating cash flow per share. Operating Cash Flow per Share returned to growth in FY2025 after 6 years of decline, reaching $-8.61.
Based on SEC 10-K filings.
-8.61 in FY2025.
Improved from $-17.91 to $-8.61 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 212This company -$8.61 Sector average -$14.72
▼
+41.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 62.4% year-over-year.
- Ranks #205 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2018.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.61 | +62.4% |
| FY2024 | -$22.92 | -28.0% |
| FY2023 | -$17.91 | -36.5% |
| FY2022 | -$13.12 | -10.6% |
| FY2021 | -$11.86 | -16.1% |
| FY2020 | -$10.21 | -277.7% |
| FY2019 | -$2.70 | -56.8% |
| FY2018 | -$1.72 | +5.4% |
| FY2017 | -$1.82 | +46.1% |
| FY2016 | -$3.38 | -265.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026